china’s two ai model company minimax and zai have grown 2x in public markets in the last month they’re now $30-35b companies surely that should prompt western labs to go public already

probably a good time to announce that there’s a better way: @clovefi a new uk wealth manager that combines ai with the best of human advice. https://t.co/Nz9FBbJgnQ
Meta AI is missing many product tricks and one is not using llama to search within WhatsApp. The thing is worse than a dumb rock - it’s probably the only AI that quite obviously still hallucinates on basic Qs. Why...
see, all the best ppl who’ve worked on performance engineering are moving into ai things gonna get better faster cheaper as a result of sheer human capital applied to the problem
interesting “While I could bridge the gap by writing skills files to explain how to automate each of my tasks, I think these skills would be personal, context-dependent, and continuously evolving. Skills alone cannot scale to become my virtual coworker.”

i wrote a lil essay on why execution-level learning changes how robots improve in production on @airstreetpress frontier robotics is moving fast in the lab, but even faster in @sereactai customer facilities today :) https://t.co/SPe81uBAAc
pricing on openai vs. anthropic is interesting and i think oai is missing out for example, chatgpt biz for $25/month buys you all the value prop of the service - i never hit rate limits meanwhile, claude pro for $20/month i max...

wait til folks see @v7labs go is doing already at scale across finance, legal, insurance, tax - not in research preview https://t.co/S8OtBtIsvI

NVIDIA is partnering with Air Street Capital on a new £2B commitment to invest in and support UK-based AI startups, providing capital, compute and technical expertise to accelerate the UK AI ecosystem. The partnership aims to scale AI infrastructure and...

Isomorphic Labs announced a $600M fundraising round, per coverage in the RAAIS 2025 speaker roundup. The raise was noted alongside the company’s continued push in AI‑first drug development.

Odyssey has raised a Series A round led by EQT Ventures with participation from Air Street and GV, announced in Nathan Benaich & Alex Chalmers' December 1, 2024 newsletter. The company secured Series A financing to support its next stage...